{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Iantrek Drive Time Podcast","title":"Meet Them Where They Are: Drs. Paul Singh and Christine Funke on AlloFlo Adoption, Patient Selection, and Surgeon Support","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/4acd2ee1\"></iframe>","width":"100%","height":180,"duration":2223,"description":"In this episode of Drive Time from Iantrek, Carey Kelson speaks with Dr. Paul Singh and Dr. Christine Funke about AlloFlo™ Uveo adoption, patient selection, and working in the uveoscleral space. They discuss why the post-MIGS treatment gap matters, which data points resonate with peers, and how AlloFlo has changed their approach to glaucoma care. Their message to the field team is clear: meet each surgeon where they are, identify the barrier, and help them build confidence with the right support.Show Notes0:59 — Carey Kelson introduces Dr. Paul Singh and Dr. Christine Funke 1:39 — How both surgeons became involved with Iantrek and AlloFlo™ Uveo 6:29 — Addressing surgeon hesitation around the uveoscleral space 9:00 — CREST data, IOP reduction, medication reduction, and safety discussion 15:27 — Practical guidance for new users: patient selection, cleft creation, and surgeon supportCreditsHost: Carey Kelson, Vice President of Market DevelopmentGuest: Dr. Paul Singh and Dr. Christine FunkeProduction: Schaefer Advertising Co.For internal use only.","thumbnail_url":"https://img.transistorcdn.com/Sy7hdvXk2MPDhLjWWhmoYVvxP2v-JD3_cqENlC9zSr0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MzM4/Nzc5N2Q0M2NmNjAz/YmExNjU5NGRjZWY2/Y2E0Mi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}